CLINICAL EFFICACY AND SAFETY OF GOLIMUMAB IN BIOLOGIC NAÏVE AND EXPERIENCED PATIENTS WITH ACTIVE ULCERATIVE COLITIS NON-RESPONDER OR INTOLERANT TO CONVENTIONAL THERAPIES.

Beatrice Orlandini  1     Elvira Capoferro  2     Siro Bagnoli  1     Gabriele Dragoni  1     Andrea Geccherle  3     Francesca Rogai    
1 IBD Unit, Careggi University Hospital,Gastroenterology,Florence,Italy
2 Ospedale sacro cuore Negrar Unita IBD Unit Colon Proctolo,Verona,Italy
3 Ospedale sacro cuore Negrar Unita IBD Unit Colon Pro

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)

Social Sharing